Bernard P. Schimmer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bernard P. Schimmer has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Martha Cordova
University of Toronto, Toronto, ON M5G 1L6, Canada
6 shared publicationsJennivine Tsao
§Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, Canada M5G 1L6
5 shared publicationsClaudia Frigeri
Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario, Canada
4 shared publications- Quaid Morris
Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, USA
3 shared publications Andrew Tsao
Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario, Canada M5G 1L6
2 shared publicationsHenry Cheng
Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario, Canada M5G 1L6
2 shared publications
Latest Publications
- 1 February 2017
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 441, 1
Seventeenth Conference on the Adrenal Cortex (Adrenal 2016) Boston, MA, March 28–31, 2016
- 1 February 2017
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 441, 1
Seventeenth Conference on the Adrenal Cortex (Adrenal 2016) Boston, MA, March 28–31, 2016
- 1 June 2015
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 408, 5-11
Corticotropin (ACTH) regulates alternative RNA splicing in y1 mouse adrenocortical tumor cells☆
- 1 June 2015
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 408, 5-11
Corticotropin (ACTH) regulates alternative RNA splicing in y1 mouse adrenocortical tumor cells☆
- 22 May 2013
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 371 (1-2) , 1
Fifteenth conference on the adrenal cortex (adrenal 2012) League City, Texas June 19–22, 2012
- 22 May 2013
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 371 (1-2) , 1
Fifteenth conference on the adrenal cortex (adrenal 2012) League City, Texas June 19–22, 2012
- 10 April 2011
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 336 (1) , 1
The Fourteenth Adrenal Cortex Conference (Adrenal 2010) and Keith L. Parker Memorial Symposium
- 10 April 2011
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 336 (1) , 1
The Fourteenth Adrenal Cortex Conference (Adrenal 2010) and Keith L. Parker Memorial Symposium
- 1 April 2011
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 336 (1-2) , 85-91
Contributions of steroidogenic factor 1 to the transcription landscape of Y1 mouse adrenocortical tumor cells
- 1 April 2011
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 336 (1-2) , 85-91
Contributions of steroidogenic factor 1 to the transcription landscape of Y1 mouse adrenocortical tumor cells
- 5 March 2009
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 300 (1-2) , 1
Conference on the Adrenal Cortex 2008, Burlingame, CA June 11–14, 2008
- 5 March 2009
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 300 (1-2) , 1
Conference on the Adrenal Cortex 2008, Burlingame, CA June 11–14, 2008
- Open Access
- 1 February 2009
- Published by Elsevier in Cell Metabolism
- Vol. 9 (2) , 115-116
Keith Langston Parker (1954-2008)
- 1 February 2009
- Published by Elsevier in Cell Metabolism
- Vol. 9 (2) , 115-116
Open AccessKeith Langston Parker (1954-2008)
- Open Access
- 3 April 2008
- Published by The Endocrine Society in Endocrinology
- Vol. 149 (7) , 3668-3678
Contributions of Specificity Protein-1 and Steroidogenic Factor 1 to Adcy4 Expression in Y1 Mouse Adrenal Cells
The type 4 adenylyl cyclase, Adcy4, is the least abundant of five different adenylyl cyclase isoforms expressed in the Y1 mouse adrenocortical cell line and is deficient in a Y1 mutant with impaired steroidogenic factor 1 (SF1) activity. This study examines the contributions of SF1 and other DNA promoter/regulatory elements to Adcy4 expression in the Y1 cell line and its derivative Adcy4-deficient mutant. Primer extension and in silico analyses indicate that Adcy4 transcription initiates from multiple sites just downstream of a GC-rich sequence. Luciferase reporter gene assays identify a 124-bp sequence, situated 19 bp upstream of the major transcription start site and highly conserved among several mammalian species, as the major determinant of Adcy4 expression in Y1 cells and as a site of compromised activity in the Adcy4-deficient mutant. EMSAs using competitor nucleotides and specific antibodies indicate that this conserved region contains three specificity protein (Sp)-1/Sp3-binding sites and one SF1-binding site. As determined by site-specific mutagenesis, the 5′-most Sp1/Sp3-site enhances promoter activity, whereas the middle Sp1/Sp3 and SF1 sites each repress Adcy4 promoter activity. In the Adcy4-deficient mutant, mutating the SF1 site restores Adcy4 promoter activity and knocking down SF1 with small interfering RNAs increases Adcy4 expression, confirming the contribution of SF1 to the mutant phenotype. These studies demonstrate roles for Sp1/Sp3 and SF1 in Adcy4 expression in Y1 cells and establish a repressor function for SF1 in certain promoter contexts.
- 3 April 2008
- Published by The Endocrine Society in Endocrinology
- Vol. 149 (7) , 3668-3678
Open AccessContributions of Specificity Protein-1 and Steroidogenic Factor 1 to Adcy4 Expression in Y1 Mouse Adrenal Cells
The type 4 adenylyl cyclase, Adcy4, is the least abundant of five different adenylyl cyclase isoforms expressed in the Y1 mouse adrenocortical cell line and is deficient in a Y1 mutant with impaired steroidogenic factor 1 (SF1) activity. This study examines the contributions of SF1 and other DNA promoter/regulatory elements to Adcy4 expression in the Y1 cell line and its derivative Adcy4-deficient mutant. Primer extension and in silico analyses indicate that Adcy4 transcription initiates from multiple sites just downstream of a GC-rich sequence. Luciferase reporter gene assays identify a 124-bp sequence, situated 19 bp upstream of the major transcription start site and highly conserved among several mammalian species, as the major determinant of Adcy4 expression in Y1 cells and as a site of compromised activity in the Adcy4-deficient mutant. EMSAs using competitor nucleotides and specific antibodies indicate that this conserved region contains three specificity protein (Sp)-1/Sp3-binding sites and one SF1-binding site. As determined by site-specific mutagenesis, the 5′-most Sp1/Sp3-site enhances promoter activity, whereas the middle Sp1/Sp3 and SF1 sites each repress Adcy4 promoter activity. In the Adcy4-deficient mutant, mutating the SF1 site restores Adcy4 promoter activity and knocking down SF1 with small interfering RNAs increases Adcy4 expression, confirming the contribution of SF1 to the mutant phenotype. These studies demonstrate roles for Sp1/Sp3 and SF1 in Adcy4 expression in Y1 cells and establish a repressor function for SF1 in certain promoter contexts.
- 28 February 2007
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 265-266, 1-2
A joint meeting of The Adrenal Cortex Conference and The Molecular Steroidogenesis Workshop, Boston, MA, June 20–23, 2006
- 28 February 2007
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 265-266, 1-2
A joint meeting of The Adrenal Cortex Conference and The Molecular Steroidogenesis Workshop, Boston, MA, June 20–23, 2006
- 1 February 2007
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 265-266, 102-107
A genome-wide assessment of adrenocorticotropin action in the Y1 mouse adrenal tumor cell line
- 1 February 2007
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 265-266, 102-107
A genome-wide assessment of adrenocorticotropin action in the Y1 mouse adrenal tumor cell line